跳至主要内容
临床试验/NL-OMON40146
NL-OMON40146撤回3 期

Vitamin K1 to slow vascular calcification in hemodialysis patients (VitaVasK) - Vitamin K1 and vessel calcification in dialysis

RWTH Aachen0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Male or female * 18 years of age
  • Not less than 6 months on hemodialysis
  • Cardiovascular calcification present (coronary artery volume score > 100)
  • Written consent to take part in the study
  • Life expectancy not less than 18 months

排除标准

  • Use of vitamin K
  • Known hypersensitivity against vitamin K1
  • History of thrombosis
  • Intake of vitamin K antagonists (e.g. Marcumar®) at baseline or in the 3 months prior to baseline
  • Inflammatory bowel disease
  • Short-bowel syndrome
  • Significant liver dysfunction
  • Coronary stent
  • Hemoglobin < 70 g/L
  • Women who are pregnant or breastfeeding
  • Women without sufficient contraception
  • Alcohol or drug abuse
  • Mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study
  • Subject unlikely to comply with protocol, e.g. uncooperative attitude, inability to return for follow-up-visits and unlikelihood of completing the study
  • Participation in a parallel clinical trial or participation in another clinical trial within the previous 3 months
  • Subjects who are in any state of dependency to the sponsor or the investigators
  • Employees of the sponsor or the investigators
  • Subjects who have been committed to an institution by legal or regulatory order

研究者

发起方
RWTH Aachen

相似试验

Vitamin K1 to slow vascular calcification in... | 临床试验